Japan Organoids Market Size, Share, and COVID-19 Impact Analysis, By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, and Others), By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, and Others), and Japan Organoids Market Insights, Industry Trend, Forecasts to 2035

Japan Organoids Market Insights Forecasts to 2035

• The Japan Organoids Market Size Was Estimated at USD 63.2 million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 23.35 % from 2025 to 2035
• The Japan Organoids Market Size is Expected to Reach USD 635.94 million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Japan Organoids Market Size is anticipated to Reach USD 635.94 Million by 2035, Growing at a CAGR of 23.35 % from 2025 to 2035. The organoids market in Japan is driven by various factors, including increasing demand for personalized medicines, rising incidence of chronic diseases, advancements in regenerative medicines, and increased investment in biopharmaceutical research and development.

Market Overview

Organoids are three-dimensional, miniaturized models of organs grown in the lab from stem cells or progenitor cells that mimic the structure and function of their corresponding native organs. The Japan organoids market refers to the development, production, and commercialization of organoids. There are various types of organoids, like brain, liver, intestine, lung, pancreas, kidney, and eye organoids. Organoids are important because they closely mimic real human organs, helping scientists study diseases, test new drugs, and understand how the body works without needing to use actual human or animal organs. The market for organoids in Japan is expanding quickly, mostly due to important developments in biotechnology and stem cell research. At the forefront of this innovation are prestigious organizations like the RIKEN Center for Developmental Biology, which uses cutting-edge methods to create organoids that closely resemble the composition and functionality of human organs. These advancements are changing the field of regenerative medicine, disease modeling, and drug discovery in Japan. The rising demand for personalized medicines is a key trend in this market. Personalized medicine offers a promising opportunity for treating conditions like Parkinson's and Alzheimer's.

Report Coverage

This research report categorizes the market for the Japan organoids market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan organoids market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan organoids market.

Driving Factors

The Japan organoids market is primarily driven by the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular conditions affecting around 30% of the adult population, which further drives the demand for advanced research tools like organoids, which give accurate disease modelling. Japan’s strong R&D investment and companies like Takeda using organoids for drug discovery are driving rapid growth in the organoids market. The Japanese government supports biotechnology growth through its growth strategy, promoting organoid research with funding and grants. This encourages collaboration between academia, industry, and government, boosting the Japan organoids market.

Restraining Factors

The difficulty of creating organoids requires specialized knowledge and exacting conditions for consistency and quality, which is a major restraint for this market. Additionally, variability in organoid structure and function hinders the reproducibility and consistency of results, which further limits the expansion of the market.

Market Segmentation

The Japan organoids market share is classified into type and method.   

• The intestinal organoids segment held a dominant market share in 2024 and is expected to grow at a rapid CAGR during the forecast period.    

The Japan organoids market is segmented by type into neural organoids, hepatic organoids, intestinal organoids, and others. Among these, the intestinal organoids segment held a dominant market share in 2024 and is expected to grow at a rapid CAGR during the forecast period. This is due to their crucial role in drug testing, disease modelling, and understanding gastrointestinal disorders. Additionally, they are valuable for studying complex biological diseases.

• The general submerged method for organoid culture segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.   

The Japan organoids market is segmented by method into general submerged method for organoid culture, crypt organoid culture techniques, air liquid interface (ALI) method for organoid culture, and others. Among these, the general submerged method for organoid culture segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This segmental growth is attributed to its extensive application and effectiveness. Additionally, this method is useful for the growth and maintenance of various organoid types.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan organoids market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• TokyOsaka University
• Kyoto University
• RIKEN
• Hiroshima University
• Nihon Biomatrix
• Eden Bioscience
• HiLung
• Takara Bio
• Jiksak Bioengineering, Inc.
• NPO Japan Organoid Repository
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan organoids market based on the below-mentioned segments:

Japan Organoids Market, By Type

• Neural Organoids
• Hepatic Organoids
• Intestinal Organoids
• Others

Japan Organoids Market, By Method

• General Submerged Method for Organoid Culture
• Crypt Organoid Culture Techniques
• Air Liquid Interface (Ali) Method for Organoid Culture
• Others